/
Notes to Presenter Update information on slides: Notes to Presenter Update information on slides:

Notes to Presenter Update information on slides: - PowerPoint Presentation

christina
christina . @christina
Follow
27 views
Uploaded On 2024-02-09

Notes to Presenter Update information on slides: - PPT Presentation

3 Add presenters information 10 If you have a risk assessment tool specific to your facility consider adding an image link or specific language 1618 Discuss infection control measures specific to your facility ID: 1045831

ltbi treatment tuberculosis exposure treatment ltbi exposure tuberculosis disease testing screening work risk infection specific bacteria healthcare body tested

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Notes to Presenter Update information on..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Notes to PresenterUpdate information on slides:3: Add presenter’s information 10: If you have a risk assessment tool specific to your facility, consider adding an image, link or specific language16-18: Discuss infection control measures specific to your facility23: Discuss facility specific policies for LTBI treatment (does the workplace provide it free of charge, does the individual have to seek treatment through their provider?)27: Add contact information

2. Notes to PresenterFeel free to edit this template to meet your needs and to add slides specific to your local process and/or policies. Please reach out to tuberculosis@vdh.virginia.gov with questionsMaterials in this template were updated 9/16/2020Reference documents used in development of this presentation: Tuberculosis Screening, Testing and Treatment of US Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and Centers for Disease Control and PreventionTuberculosis Screening, Testing, and Treatment of US Health Care Personnel ACOEM and NTCA Joint Task Force on Implementation of the 2019 MMWR Recommendations

3. Annual Tuberculosis (TB) Education*Presenter Name**Presenter Title**Facility**Presentation Date*

4. OverviewTuberculosis Disease vs. Latent Tuberculosis InfectionRisk Assessment, Screening and TestingTB TransmissionInfection ControlTB SymptomsTB TestingLTBI Treatment

5. TuberculosisTuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but TB bacteria can attack any part of the body.Not everyone infected with TB bacteria becomes sick.Latent TB infection (LTBI)TB disease

6. LTBI vs. TB Disease

7. TB Screening, Testing and Treatment of U.S. Healthcare Personnel Updated guidance released in May of 2019 to supplement the 2005 guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings

8. TB in the United States

9. TB Screening, Testing and Treatment of U.S. Healthcare Personnel

10. Baseline Preplacement Screening and Testing

11. Annual TB TestingCertain groups of HCP at high risk of TB exposure at work may still be tested annually (e.g., clinicians working in a TB clinic).You will be notified if you are in one of these groups.

12. TB Screening/Testing after ExposureHCP who have an exposure to TB at work will be tested immediately after the exposure and again 8-10 weeks after the exposure. HCP who have an exposure outside of work should report potential exposure to occupational health and should be tested. Exposures outside of work could include:Spending more than 30 days in a country where TB is commonHaving close contact with someone with active TBWorking in a healthcare setting in a country where TB is common

13. AirborneM. tuberculosis is carried in airborne particlesWhen a person who has TB in the lungs or throat coughs, sneezes, shouts or sings, particles are released into the air. Depending on the environment, TB can remain suspended in the air for several hours. Transmission/exposure occurs when a person breathes in the bacteria from the air. The bacteria can move from the lungs through the blood to other parts of the body. TB not in the lungs or throat is not considered infectious.TB Transmission/Exposure

14. TB – Probability of TransmissionMany factors impact the probability of transmission of M. tuberculosis: Susceptibility of the person exposedInfectiousness of the person with active TBEnvironmentSpaceVentilationAir circulationSpecimen handlingAir pressureConcentration of infectious droplet nucleiExposureUse of personal protective equipment (PPE)ProximityLength

15. Infection ControlAdministrative ControlsEnvironmental ControlsRespiratory Protection

16. Implement effective work practices to manage patients who may have TB diseaseTest and evaluate HCP at risk for TB exposureEducation and training This annual education!Posters/signs about cough etiquette & respiratory hygieneDetermine need for airborne isolation roomsFacility risk assessmentAdministrative Controls

17. Environmental ControlsVentilation Natural (windows, doors)Mechanical Equipment to circulate & move airDilution and removal of contaminated airAirborne isolation rooms (negative pressure)CleaningHigh efficiency particulate air (HEPA) filtersUltraviolet germicidal irradiation (UVGI)

18. Respiratory ProtectionUse of Personal Protective Equipment (PPE)If you work with TB patients or in the room of TB patients, you will be enrolled in the respiratory protection program and will be medically evaluated and fit-tested annually for an appropriate respirator.

19. TB Incubation PeriodWeeksYearsLifetime

20. TB SymptomsPulmonary TB DiseaseCoughHemoptysis (blood in cough or sputum)Unexplained weight loss/loss of appetiteNight sweatsFeverFatigueExtrapulmonary TB DiseaseRelated to body part affected by the diseaseCould also include weight loss, night sweats, fever, fatigue etc.

21. TB Testing and Diagnosis Two methods for detection of TB infection:Mantoux tuberculin skin test (TST)Interferon-gamma release assays (IGRAs)QuantiFERON-TB Gold Plus (QFT-Plus)T-SPOT.TB testMedical historyPhysical examinationChest x-rayBacteriologic examination of clinical specimens

22. TB Testing and Diagnosis At hire or after an exposure, if you have a positive test for LTBI, you will have a chest x-ray performed to rule out active disease. If your x-ray is normal, LTBI treatment will be offered. Completing treatment for LTBI means that your infection will not progress to active disease so you will not become sick or make others sick at work or at home. If you refuse treatment, you will receive an annual symptom review and encouragement to start treatment

23. LTBI TreatmentSource: www.cdc.gov/tb/topic/treatment/pdf/LTBITreatmentRegimens.pdf

24. Financial and Personal Cost of LTBI vs. TBA Typical LTBI Case Requires:

25. Risk FactorsCertain medical conditions and risk factors make it more likely that an individual will progress from LTBI to TB disease: HIV infection Substance abuseSilicosisDiabetes mellitusSevere kidney diseaseLow body weightOrgan transplantsHead and neck cancerMedical treatments such as corticosteroids or organ transplantSpecialized treatment for rheumatoid arthritis or Crohn’s disease

26. Key Points

27. Questions? Contact: *Add contact info*